PTGS2 and non-small cell lung carcinoma: Furthermore, biological targets predicted by SwissTargetPrediction and PharMapper servers suggest that the COX-2 is the best NSCLC-related targets for NafoQs (Figure 10 and Supplementary Figure S1).